medigraphic.com

2021, Number 2

<< Back Next >>

Rev Fac Med UNAM 2021; 64 (2)

Transcervical Excision of a Giant Mediastinal Parathyroid Adenoma

Barrientos LIA, Castillo VBB

Language: Spanish
References: 14
Page: 38-45
PDF size: 252.66 Kb.


ABSTRACT

Primary hyperparathyroidism (HPTP) is the third most common neuroendocrine disorder, its main cause is parathyroid adenoma. Within the classification, those adenomas that weigh more than 3.5 g are classified as giant parathyroid adenomas (APG), and are associated with a worse evolution and malignancy. The purpose of this article is to present our diagnostic and therapeutic approach of a patient with HPTP associated with a mediastinal APG. A search in the international literature of the last 10 years revealed that only 8 other centers have reported the extraction of an APG of similar dimensions to ours and in a similar location.
Case presentation: A 66-year-old woman with a history of multinodular goiter, thyroid profile and parathormone (PTH) measurement were requested, with a report of 350.60 pg/ mL. A thyroid/parathyroid scintigraphy was performed with 99mTc sestaMIBI which reported persistence of a focal area of the concentration located in the topography of the lower pole of the right thyroid lobe. This study was complemented with SPECT-CT, which reported an image of hyperfunctioning right inferior parathyroid compatible with adenoma and the patient was diagnosed with PTH. Finally, resection was performed, obtaining a tumor measuring 7.0 × 4.5 × 2.0 cm, with a weight of 24.5 g.
Conclusions: Our case highlights the use of imaging studies to facilitate localization and achieve diagnosis together with clinical presentation and biochemical profile. Selective treatment was achieved safely through a minimally invasive transcervical technique, combined with the measurement of PTH.


REFERENCES

  1. Neagoe R, Sala D, Borda A, Mogoantá C, Műhlfay G. Clinicopathologic and therapeutic aspects of giant parathyroid adenomas – three case reports and short review of the literature. Rom J Morphol Embryol. 2014;55(2 Suppl):669-74.

  2. Marcio L Griebeler, Ann E Kearns, Euijung Ryu, et al. Secular trends in the incidence of primary hyperparathyroidism over five decades (1965-2010). Bone. 2015;73:1-7.

  3. Mendoza VZ, et al. Hiperparatiroidismo primario. Experiencia en el Hospital de Especialidades Centro Médico Nacional Siglo XXI. Revista de Endocrinología y Nutrición. 2009;17(1):13-20

  4. Sadiq NM, Naganathan S, Badireddy M. Hypercalcemia. [Actualizado el 10 de septiembre de 2020]. En: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 enero. Disponible en: https://www.ncbi.nlm.nih. gov/books/NBK430714/

  5. Silverberg SJ, Lewiecki EM, Mosekilde L, Peacock M, Rubin MR. Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab. 2009 Feb;94(2):351- 65. doi: 10.1210/jc.2008-1760.

  6. Marcocci C, Cetani F. Clinical practice. Primary hyperparathyroidism. N Engl J Med. 2011 Dec 22;365(25):2389- 97. doi: 10.1056/NEJMcp1106636.

  7. Spanheimer PM, Stoltze AJ, Howe JR, Sugg SL, Lal G, Weigel RJ. Do giant parathyroid adenomas represent a distinct clinical entity? Surgery. 2013;154(4):714-9. doi: 10.1016/j.surg.2013.05.013.

  8. Yao K, Singer F, Roth S, Sassoon A, Ye C, AE G. Weight of normal parathyroid glands in patients with parathyroid adenomas. J Clin Endocrinol Metab. 2004;90(1):595.

  9. Cupisti K, Dotzenrath C, Simon D et al. Therapy of suspected intrathoracic parathyroid adenomas. Langenbecks Arch Surg. 2002;386:488-93

  10. Caporale DM, Bobbio A, Accordino R, et al. Ectopic mediastinal parathyroid adenoma. Acta Biomed. 2003;74: 157-9.

  11. Neumann DR, Obuchowski NA, Difilippo FP. Preoperative 123I/99mTc-sestamibi subtraction SPECT and SPECT/ CT in primary hyperparathyroidism. J Nucl Med. 2008; 49:2012-7.

  12. Bilezikian JP, Khan AA, Potts JT Jr. Third International Workshop on the Management of Asymptomatic Primary Hyperthyroidism. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. J Clin Endocrinol Metab. 2009 Feb;94(2):335-9. doi: 10.1210/ jc.2008-1763. PMID: 19193908; PMCID: PMC3214274.

  13. Udelsman R, Lin Z, Donovan P. The superiority of minimally invasive parathyroidectomy based on 1650 consecutive patients with primary hyperparathyroidism. Ann Surg. 2011 Mar;253(3):585-91. doi: 10.1097/SLA.0b013e318208fed9. PMID: 21183844.

  14. Shields TW, Immerman SC. Mediastinal parathyroid cysts revisited. Ann Thorac Surg. 1999;67:581-90.




2020     |     www.medigraphic.com